Sweet
Virginia cigarette, burning in my hand.
You
used to be a friend of mine, but now I understand.
You've
been eating up inside me for some time.
Oh,
in the morning there'll be hell to pay, somewhere along the line
In
the morning there'll be hell to pay, somewhere along the line."
-- Billy Joel
1:05 p.m. Monday, Jan. 16, 2012.
Richard, the oncology nurse,
plugs in the first bag of a platinum-based chemotherapy drug called Cisplatin into
my IV line. Poison to kill the poison; an elixir that may or may not extend my
life. I'm in the transfusion center of the Kaiser Permanente Medical Center in
beautiful Parma, Ohio.
It's a large room with 15 or so
vinyl reclining chairs of various vintage and design lining three walls and
wherever else they can be squeezed in. Dress up the place and give it some
charm and it could be a waiting room for a tire store.
I have a corner office next to a
cabinet containing sheets and blankets. In a room where privacy doesn't exist,
it's the best I can do. And I am a private person, which makes this exercise an
interesting and strange byproduct of the strange and overwhelming circumstances
that I find myself in today and for the unforeseen future.
This Cisplatin is in a big bag. Richard
tells me it will take about two hours to empty. Dr. Verma had talked to me that
morning about the side effects. As many chemo drugs do, it causes your hair to
fall out. Truly, that’s a minor inconvenience. There's neuropathy -- tingling
and loss of feeling in the extremities – potentially permanent hearing loss and
numerous other bad things.
I don’t care. Bring it on. It’s
not like I have a choice. Guess what kids? I want to live.
Richard, a long, tall
compassionate soul keeps a close eye on me. His concern seems genuine. But he
and his fellow nurses are busy. Lots of sick people show up every day at Kaiser
to do battle with cancer and other serious illnesses that require IVs and bags
of medicine.
While a doctor had told me a
month ago that I more than likely had cancer, the official diagnosis came less
than two weeks ago from a surgeon who had hoped to cut out the tumor. But
things were not quite so simple, he explained. The pathologist had found a confusing
mix of non-small and possibly small cell cancer in the biopsy.
They needed to send the biopsy
elsewhere, the surgeon said. He said a finding of non-small cell would be “good.”
Small cell, which has a nasty habit of spreading like wildfires in a dry wind, are not so good. Surgery is not an option. Nice choices. Then again, neither was 35 years of cigarettes.
Small cell, which has a nasty habit of spreading like wildfires in a dry wind, are not so good. Surgery is not an option. Nice choices. Then again, neither was 35 years of cigarettes.
I received a call three days ago
– Friday, Jan. 13 -- from Dr. Ravi Verma, the oncologist I’d met just the day
before. He confirmed what everyone expected. I had hit the lung cancer daily double: small cell and non-small cell. No surgery for
me. He said he’d seen three such cases in almost 20 years of practice.
“Mark, I need you to come in and
begin chemotherapy on Monday,” Verma. said.
I did not respond as I gathered my thoughts.
“You can begin Tuesday if you’d like.” he added. I told him Monday would be fine.
I did not respond as I gathered my thoughts.
“You can begin Tuesday if you’d like.” he added. I told him Monday would be fine.
Monday would not be fine. The
day after never would be mighty fucking fine, thank you very much. Thoughts
about this new reality began pummeling an already fragile psyche.
We discussed time and place and
I managed to ask one question before I got off the phone. What's my survival rate?
“It’s 15 percent if you remain
cancer free after five years,” he said.
Oh. That's not good. Not good at all.
No comments:
Post a Comment